CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Cardiff Oncology, Inc. - CRDF CFD

2.6543
5.57%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0314
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024818 %
Charges from full value of position ($-4.72)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024818%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002596 %
Charges from full value of position ($0.49)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002596%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.5143
Open 2.5043
1-Year Change 55.07%
Day's Range 2.5043 - 2.6843
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 19, 2024 2.5143 0.0000 0.00% 2.5143 2.6943 2.4343
Sep 18, 2024 2.4543 -0.1500 -5.76% 2.6043 2.6443 2.4143
Sep 17, 2024 2.5243 -0.0200 -0.79% 2.5443 2.6043 2.4343
Sep 16, 2024 2.5543 -0.1400 -5.20% 2.6943 2.8043 2.4543
Sep 13, 2024 2.6843 0.2000 8.05% 2.4843 2.7443 2.4843
Sep 12, 2024 2.5443 0.2600 11.38% 2.2843 2.6643 2.2743
Sep 11, 2024 2.3043 0.1300 5.98% 2.1743 2.3043 2.1643
Sep 10, 2024 2.2816 0.1100 5.07% 2.1716 2.3116 2.1716
Sep 9, 2024 2.2916 0.2200 10.62% 2.0716 2.3116 2.0716
Sep 6, 2024 2.0916 -0.1300 -5.85% 2.2216 2.2416 2.0816
Sep 5, 2024 2.1916 0.0500 2.33% 2.1416 2.2216 2.1016
Sep 4, 2024 2.1716 0.0000 0.00% 2.1716 2.2316 2.1316
Sep 3, 2024 2.1816 -0.0600 -2.68% 2.2416 2.2916 2.1416
Aug 30, 2024 2.2816 0.0200 0.88% 2.2616 2.3016 2.2216
Aug 29, 2024 2.2716 0.0100 0.44% 2.2616 2.3516 2.2216
Aug 28, 2024 2.2816 -0.0200 -0.87% 2.3016 2.3116 2.2316
Aug 27, 2024 2.3216 -0.0400 -1.69% 2.3616 2.4016 2.2716
Aug 26, 2024 2.3816 -0.0300 -1.24% 2.4116 2.4316 2.3516
Aug 23, 2024 2.3716 0.1100 4.86% 2.2616 2.4516 2.2616
Aug 22, 2024 2.2816 -0.0200 -0.87% 2.3016 2.3316 2.2616

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cardiff Oncology, Inc. Company profile

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin. The company''s onvansertib is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. In addition, it develops therapeutics, such as belinostat (Beleodaq); quizartinib (AC220), a development stage FLT3 inhibitor; and bortezomib (Velcade) for the treatment of leukemias, lymphomas, and solid tumor cancers. The company primarily serves pharmaceutical companies. Cardiff Oncology, Inc. has a research collaboration with Nektar Therapeutics for the treatment of colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2020. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Industry: Biotechnology & Medical Research (NEC)

11055 Flintkote Ave
SAN DIEGO
CALIFORNIA 92121
US

News

RBA Preview: Rates to remain unchanged with inflation-fighting still the focus

RBA Governor Michelle Bullock emphasizes inflation challenges for Australia's economy, citing supply shocks and demand-supply imbalances. Discover insights on CPI trends, interest rates, and the central bank's strategy for managing price pressures in 2024.

12:27, 20 September 2024

BoE Preview: no change expected but forward guidance will be key

The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.

14:53, 19 September 2024

FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion

Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.

11:30, 19 September 2024

Bank of Japan Preview

The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.

09:40, 17 September 2024

FOMC Decision Preview

As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.

09:48, 16 September 2024

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

People also watch

XRP/USD

0.59 Price
-1.600% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

62,954.40 Price
-0.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,622.64 Price
+1.370% 1D Chg, %
Long position overnight fee -0.0181%
Short position overnight fee 0.0099%
Overnight fee time 21:00 (UTC)
Spread 0.60

US100

19,782.90 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0248%
Short position overnight fee 0.0026%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading